NewsCorporate ActionsGujarat Themis Biosyn: Themis Medicare pledges 3.5 lakh shares to Jio Credit LimitedGujarat Themis Biosyn: Themis Medicare pledges 3.5 lakh shares to Jio Credit Limited
Themis Medicare Limited pledged 3,50,000 equity shares of Gujarat Themis Biosyn Limited to Jio Credit Limited on January 12, 2026, against a ₹10 crore borrowing facility. The pledge aims to repay high-interest loans and reduce finance costs. Post-transaction, Themis Medicare's total encumbered shareholding increased to 12,70,000 shares (1.38% of total capital).
*this image is generated using AI for illustrative purposes only.
Themis Medicare Limited has pledged 3,50,000 equity shares of Gujarat Themis Biosyn Limited to Jio Credit Limited on January 12, 2026, as part of a strategic financing arrangement. The disclosure was made under Regulation 31 of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
Share Pledge Details
The pledge transaction involves key financial parameters that reflect Themis Medicare's shareholding structure in Gujarat Themis Biosyn:
| Parameter: | Details |
|---|---|
| Shares Pledged: | 3,50,000 equity shares |
| Pledge Date: | January 12, 2026 |
| Beneficiary: | Jio Credit Limited |
| Facility Amount: | ₹10.00 crores |
| Percentage of Total Capital: | 0.38% |
Shareholding Position
Themis Medicare Limited maintains a significant stake in Gujarat Themis Biosyn, with the recent pledge affecting its encumbered shareholding position:
| Shareholding Metric: | Before Pledge | After Pledge |
|---|---|---|
| Total Holding: | 2,52,72,037 shares (23.19%) | 2,52,72,037 shares (23.19%) |
| Previously Encumbered: | 9,20,000 shares (1.00%) | - |
| Total Encumbered: | - | 12,70,000 shares (1.38%) |
Purpose and Strategic Rationale
The share pledge serves a specific financial objective for Themis Medicare Limited. The company has entered into a facility cum pledge agreement with Jio Credit Limited to access borrowing facilities worth ₹10.00 crores. The primary purpose of this arrangement is to facilitate the repayment of existing high-interest-bearing loans, thereby reducing the overall finance cost burden on the company.
Regulatory Compliance
The disclosure was filed on January 14, 2026, in compliance with SEBI regulations governing substantial acquisition of shares and takeovers. Gujarat Themis Biosyn Limited's shares are listed on both BSE Limited and National Stock Exchange of India Limited, making the regulatory disclosure mandatory for such encumbrance transactions.
The pledge represents a routine corporate financing activity where promoter companies utilize their shareholdings as collateral to access favorable borrowing terms and optimize their capital structure.
Historical Stock Returns for Gujarat Themis Biosyn
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +1.40% | -11.34% | -4.60% | +7.87% | +52.82% | +52.82% |
17
